Amy Articolo

Executive Director, Global Medical Affairs at Novo Nordisk

Amy Articolo is an experienced medical professional with a strong background in bariatric medicine and obesity treatment. Currently serving as the Lead Liver Health Unit and Medical Director for both NASH and Obesity/NASH at Novo Nordisk since June 2018, Amy has previously held leadership positions at the Obesity Treatment Foundation and Salvéo Weight Management, where emphasis was placed on advancing clinical research and providing chronic care for bariatric patients. Amy also contributed to educational revitalization as a board member for the Franklin Foundation for Innovation and practiced as an Obstetrician/Gynecologist at Garden State Ob/Gyn Associates. Academic qualifications include a Doctor of Osteopathy from the Philadelphia College of Osteopathic Medicine and dual Bachelor's Degrees in American History and English Literature from the University of Pennsylvania.

Location

Plainsboro, United States

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Novo Nordisk

378 followers

Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.


Industries

Headquarters

Bagsværd, Denmark

Employees

10,000+

Links